Modern biology has long relied on techniques that analyse cells in isolation. While bulk and single cell sequencing have provided deep molecular insights, they often miss a crucial dimension: spatial context. In spatial biology, preserving tissue architecture is essential for understanding how cells interact within their native microenvironment.

TSA-based multiplex immunofluorescence (mIF) addresses this limitation by enabling high sensitivity detection of multiple protein targets within intact tissue sections. By combining TSA with sequential staining strategies, researchers can map functional protein expression while maintaining spatial relationships between cells.

Why Spatial Context Matters in Multiplex Immunofluorescence

Traditional techniques such as bulk sequencing and even single-cell sequencing typically require tissue dissociation. While these methods reveal valuable information about gene or protein expression, they disrupt the spatial relationships between cells.

However, in many biological processes, location is as important as molecular identity. For example:

• In Oncology: The proximity of immune cells to cancer cells can determine whether an immune response is effective.
• In Neuroscience: Neuronal function depends on precise spatial organisation.
• In Development: Gradients of signalling molecules guide tissue formation.

Without spatial information, we lose sight of cell–cell interactions, functional niches, and the microenvironmental influences that drive disease progression. TSA-based mIF within a spatial biology framework enables high sensitivity protein mapping while preserving these critical spatial relationships.

The Spatial Biology Toolkit: From mIF to Spatial Omics

Multiplex immunofluorescence (mIF) is a cornerstone technique in spatial biology, enabling detection of multiple protein markers on a single tissue section while preserving tissue architecture. In many high-sensitivity workflows, mIF incorporates Tyramide Signal Amplification, often referred to as TSA-based mIF, to enhance signal intensity and enable reliable detection of low-abundance protein targets.

While mIF provides high-resolution protein-level insight, spatial biology encompasses a broader toolkit often referred to as spatial omics. These technologies enable molecular mapping at scale within intact tissues, including:

• Spatial transcriptomics — Capturing the whole transcriptome (10,000 genes) in situ
• Spatial proteomics — Quantifying proteins via antibodies or mass spectrometry
• Multi-omic platforms — Integrating RNA, protein, metabolites, and epigenetic information simultaneously
• Computational spatial mapping — Using AI to reconstruct cellular neighbourhoods and inferring interactions

Together, these approaches provide complementary layers of information. Spatial transcriptomics supports unbiased discovery, whereas TSA-based mIF delivers high-sensitivity protein validation within preserved tissue architecture. This multi-layered framework allows researchers to interpret molecular programmes in the context of cellular organisation and microenvironmental structure.

Designing a Spatial Biology Experiment

Careful experimental design is critical for generating reliable spatial biology data, particularly when implementing TSA-based mIF workflows.

1. Define the biological question – Identify whether the focus is immune microenvironments, tumour heterogeneity, tissue development, or disease mechanisms.
2. Marker selection – Choose markers that define cell types, functional states, or signalling pathways.
3. Tissue preparation – Different tissue types may require FFPE, fresh frozen, or specialised clearing techniques for imaging.
4. Technology selection – Decide between mIF, imaging mass cytometry, spatial transcriptomics, or multi-omic platforms depending on required resolution, throughput, and molecular coverage.
5. Data analysis planning – Spatial datasets are complex, often requiring advanced computational pipelines for segmentation, clustering, and interaction mapping.

Choosing the Right Spatial Platform for Your Biological Question

Selecting the right spatial biology platform is often the most challenging step in experimental design. It is tempting to pursue the highest plex method available, but the most appropriate technology is the one that answers your specific biological question with sufficient resolution, sensitivity, throughput, and reproducibility.

While this guide focuses on TSA-based multiplex immunofluorescence (mIF), it is essential to understand how it compares to other leading spatial technologies. The table below outlines common scenarios to help determine when TSA-mIF is the optimal choice—and when alternatives may be better suited.

Technology	Best Used For	Plex Capacity	Sensitivity	Why Choose TSA-mIF Instead?
TSA-based mIF	Validating 4–10 markers; high-sensitivity detection of “dim” targets.	4–10	Highest (10-100x boost)	Cost-effective. Uses standard lab microscopes; covalent signal allows stripping without data loss.
PhenoCycler (CODEX)	High-plex discovery; mapping 40+ cell types in a single tissue.	40–60+	Moderate	Less Complexity. PhenoCycler requires specialised fluidics and expensive barcodes; TSA is better for low-abundance proteins.
Imaging Mass Cytometry (IMC)	Autofluorescence-heavy tissues (Lung/Liver); absolute quantification.	40+	Low to Moderate	Higher Resolution. IMC resolution is often limited to 1µm; TSA-mIF offers crisp subcellular detail and much higher signal.
Spatial	Whole-transcriptome discovery; RNA-focused questions.	1,000–10,000+	Variable	Protein is King. RNA levels don’t always equal protein levels. TSA validates the “functional” protein expression in situ.

Deep Dive: Tyramide Signal Amplification

As we move toward higher-plex imaging, traditional staining methods often struggle with weak signals. Tyramide Signal Amplification (TSA) has emerged as a key technology to bridge this gap.

Note on scope: Spatial omics encompasses RNA, protein, and metabolite mapping. This section focuses specifically on multiplexed protein imaging, where sensitivity is often the limiting factor. While spatial transcriptomics captures the blueprint of gene expression, spatial proteomics reveals the functional state of cells—post-translational modifications, activated signalling pathways, and therapeutic target engagement. TSA is the critical enabling chemistry for this domain.

How TSA Works

TSA is an enzyme-mediated detection method that uses Horseradish Peroxidase (HRP) to catalyse the deposition of labelled tyramide molecules. These reactive radicals bind covalently to nearby tyrosine residues on the tissue.

The result? A signal that is 10–100 times stronger than conventional IHC. Because the bond is covalent, the fluorescent signal stays “locked” in place even if the primary antibodies are stripped away to make room for the next round of markers.

Why TSA is Essential for Multiplexing

1. High Sensitivity: It enables the detection of low-abundance or “dim” markers that would otherwise be lost in background noise.
2. Sequential Multiplexing: Researchers can stain, strip the antibodies, and repeat. The TSA signal remains, allowing for the visualisation of dozens of markers on one slide.
3. Spatial Precision: The radicals diffuse only a tiny distance before binding, ensuring clear cell boundaries and minimal “bleed” between structures.

TyraMax™: Best in Class Brightness and Photostability for TSA Multiplex IHC

Choosing the right amplification chemistry is the most critical decision in panel development. While several commercial options exist, researchers prioritise brightness, photostability, and ease of automation.

When evaluating the best TSA kits, Biotium offers standout tailored for specific research needs:

By selecting kits that offer high signal-to-noise ratios and chemical stability, labs can significantly reduce the “trial and error” often associated with high-plex TSA workflows.

TSA-based multiplexing Practical Challenges and Strategies

Despite its strengths, TSA-based multiplexing presents practical challenges:

• Complexity and manual labour – Multiple staining, washing, and amplification cycles make the workflow labour-intensive and prone to variation.
• Extended protocol times – Sequential staining cycles increase total assay duration.
• High reagent consumption – Repeated amplification cycles require large amounts of antibodies and tyramide reagents, raising cost and optimisation effort.
• Signal crosstalk or bleed-through – High-plex workflows can experience overlapping fluorescence if not carefully planned.
• Antigen degradation or masking – Repeated retrieval and stripping steps can damage sensitive tissue epitopes.

Strategies to overcome these challenges include:

• Automated and standardised workflows – Reduce manual handling, improve reproducibility, and accelerate staining cycles.
• Protocol optimisation – Careful antibody titration, strategic marker staining order, and fine-tuning tyramide concentration.
• Advanced imaging planning – Selecting fluorophores with minimal spectral overlap and balancing high- versus low-abundance markers

Well-optimised TSA workflows enable reliable, reproducible, and high-resolution spatial maps of protein expression within tissues.

The Future of TSA-Based Multiplex Immunofluorescence in Spatial Biology

The future of spatial biology lies in integration. Advances in AI-driven image analysis are enabling correlation of a cell’s genetic state with its physical location and neighbouring proteomic profile within intact tissue. As TSA-based multiplex immunofluorescence workflows become more automated and higher-throughput, high-sensitivity spatial protein mapping is increasingly positioned to support translational research and clinical diagnostics.

References

Bressan D, Battistoni G, Hannon GJ. The dawn of spatial omics. Science. 2023 Aug 4;381(6657):eabq4964. doi: 10.1126/science.abq4964.

Liu Y, Dai Y, Wang L. Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications. Cancer Cell. 2026 Jan 12;44(1):24-49. doi: 10.1016/j.ccell.2025.12.009.

Moffitt JR, Lundberg E, Heyn H. The emerging landscape of spatial profiling technologies. Nat Rev Genet. 2022 Dec;23(12):741-759. doi: 10.1038/s41576-022-00515-3.

Radosevic-Robin N, Kossai M, Penault-Llorca F. New-generation technologies for spatial tissue analysis, indispensable tools for deciphering intratumor heterogeneity in the development of antibody-drug conjugates and radio-immunoconjugates for cancer treatment. Transl Breast Cancer Res. 2023 Sep 20;4:28. doi: 10.21037/tbcr-23-38.

Sheng W, Zhang C, Mohiuddin TM, Al-Rawe M, Zeppernick F, Falcone FH, Meinhold-Heerlein I, Hussain AF. Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy. Int J Mol Sci. 2023 Feb 4;24(4):3086. doi: 10.3390/ijms24043086.

Stack EC, Wang C, Roman KA, Hoyt CC. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods. 2014 Nov;70(1):46-58. doi: 10.1016/j.ymeth.2014.08.016.

Tan WCC, Nerurkar SN, Cai HY, Ng HHM, Wu D, Wee YTF, Lim JCT, Yeong J, Lim TKH. Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun (Lond). 2020 Apr;40(4):135-153. doi: 10.1002/cac2.12023.